Real-world comparative outcomes of atorvastatin, rosuvastatin, and lovastatin–niacin fixed-dose combination in metabolic dysfunction-associated steatotic liver disease: hepatic, metabolic, and economic perspectives

Yi Tseng Tsai, Sriyani Padmalatha Konara Mudiyanselage, Yi‑Jing Tsai, Sujeewa Dilhani Maithreepala, Wen-Chun Liu, Nai‑Ying Ko, Jen-Hao Yeh, Chiu Wei-Lin, Ping-I Hsu, Chu‑Kuang Chou, Kun-Feng Tsai · 2026

Read Real-world comparative outcomes of atorvastatin, rosuvastatin, and lovastatin–niacin fixed-dose combination in metabolic dysfunction-associated steatotic liver disease: hepatic, metabolic, and economic perspectives by Yi Tseng Tsai, Sriyani Padmalatha Konara Mudiyanselage, Yi‑Jing Tsai, Sujeewa Dilhani Maithreepala, Wen-Chun Liu, Nai‑Ying Ko, Jen-Hao Yeh, Chiu Wei-Lin, Ping-I Hsu, Chu‑Kuang Chou, Kun-Feng Tsai (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13560391.txt.

Description

Yi Tseng Tsai and ten colleagues compare three statin regimens in metabolic dysfunction-associated steatotic liver disease. Statins are widely used in this disease, but head-to-head evidence on efficacy, safety, and cost stays thin. Their 2026 retrospective cohort reviews records from a teaching hospital in southern Taiwan. After matching, 729 patients took daily atorvastatin, rosuvastatin, or lovastatin-niacin for six months.

All three regimens cut liver and lipid markers significantly over six months. Lovastatin-niacin cut ALT and AST most, with about 54 percent reaching at least a 30 percent AST drop, against under 30 percent for the statins. ALT response reached about 40 percent versus about 31 percent for the statins. Statins raised HDL cholesterol more, while lovastatin-niacin cut triglycerides and cost less per benefit, with more flushing.

Catalog record

CREATORYi Tseng Tsai, Sriyani Padmalatha Konara Mudiyanselage, Yi‑Jing Tsai, Sujeewa Dilhani Maithreepala, Wen-Chun Liu, Nai‑Ying Ko, Jen-Hao Yeh, Chiu Wei-Lin, Ping-I Hsu, Chu‑Kuang Chou, Kun-Feng Tsai
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13560391

Browse the full library · About the Tower of Babel